BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26884883)

  • 1. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
    Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
    Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
    Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
    Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
    PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
    Fu T; Qu W; Qiu F; Li Y; Shao G; Tian W; Hua Z; Zhang Y; Wang F
    Cancer Biother Radiopharm; 2014 Nov; 29(9):351-8. PubMed ID: 25286251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.
    Zhang Z; Zhao X; Ding C; Wang J; Zhang J; Wang F
    Cancer Biother Radiopharm; 2016 Sep; 31(7):238-45. PubMed ID: 27563805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
    Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
    Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin Imaging with
    Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
    Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
    Ji S; Zhou Y; Voorbach MJ; Shao G; Zhang Y; Fox GB; Albert DH; Luo Y; Liu S; Mudd SR
    J Pharmacol Exp Ther; 2013 Aug; 346(2):251-8. PubMed ID: 23750021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of [
    Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
    Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.
    Apostolopoulos DJ; Koletsis EN; Spyridonidis T; Paschali A; Papandrianos N; Stamou E; Vassilakos PJ; Dougenis D
    Ann Nucl Med; 2014 Jun; 28(5):463-71. PubMed ID: 24668640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
    Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
    J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
    Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
    Yang JJ; Wang SX; Zhong WZ; Xu CR; Yan HH; Wu YL
    Nucl Med Commun; 2011 Dec; 32(12):1113-20. PubMed ID: 21934546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
    Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
    J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of technetium-99m hexakis-2-methoxyisobutyl isonitrile in the detection of neoplastic lung lesions.
    Santini M; Fiorello A; Mansi L; Rambaldi PF; Vicidomini G; Busiello L; Messina G; Nargi P
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):325-31. PubMed ID: 18996706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of simultaneous double-tracer SPECT with 99m-Tc-technetril and 67-Ga-citrate for follow-up of patients with non-small cell lung cancer].
    Kanaev SV; Novikov SN; Beĭnusov DS; Girtovich MM; Levchenko EV; Barchuk AS; Semënov II; Zhukova LA; Matsko DE
    Vopr Onkol; 2012; 58(3):346-51. PubMed ID: 22888649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
    de Jong EE; van Elmpt W; Leijenaar RT; Hoekstra OS; Groen HJ; Smit EF; Boellaard R; van der Noort V; Troost EG; Lambin P; Dingemans AC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):8-16. PubMed ID: 27600280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancer.
    Yang TJ; Aukema TS; van Tinteren H; Burgers S; Valdés Olmos R; Verheij M
    Mol Imaging Biol; 2010 Apr; 12(2):174-80. PubMed ID: 19756867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.